Burmeister, Bryan H <br/><br/>
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Dec 2011 
 - 2076-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e31822d53a9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anorexia--etiology<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--analogs & derivatives<br/>Disease-Free Survival<br/>Dose Fractionation, Radiation<br/>Dyspnea--etiology<br/>Fatigue--etiology<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Lung Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Proportional Hazards Models<br/>Quality of Life<br/>Treatment Outcome<br/>Vinblastine--administration & dosage<br/>Vinorelbine<br/>Gemcitabine